Legal & RegulatoryEvent: September 1, 2026
CergenX team announced that Wave, an AI-powered technology providing rapid, objective insights into newborn brain activity, has officially achieved CE Mark certification under EU MDR 2017/745.
Published
Signal category
Legal & Regulatory
Quote
“Wave, our AI powered technology providing rapid, objective insights into newborn brain activity, has officially achieved CE Mark certification under EU MDR 2017/745”
— CergenX team
Company
CergenX
Transforming brain health through AI-powered clinical insights
- Industry
- Software Development
- Location
- Cork, Dublin, IE
- Company size
- 21 employees
CergenX is an Irish medtech company transforming newborn brain health through AI-powered clinical insights. Our first product, Wave, uses EEG and artificial intelligence to provide clinicians with rapid, objective insights into newborn brain activity and abnormalities associated with brain injury.